Health & Biotech
Prescient unveils latest big hitter CellPryme-A at prestigious Boston CAR-TCR meeting
Check Up: These 3 biotechs join the elite ASX 300 this week – and it could be a game-changer
Interim results show MGC Pharma’s CimetrA dose finding study on right track
ASX Health Stocks: Telix and Imugene keep making progress on cancer studies
ASX Health Stocks: Alterity jumps 20pc after FDA approves its clinical trial in the US
ASX Health Stocks: Polynovo leaps 12pc after coming out of trading halt, gets FDA approval
Opyl appoints news chairman as it eyes international growth
Neurotech’s ground-breaking study of cannabis in children on the spectrum progresses
Weed Week: The lazy stoner stereotype is a myth and this Aussie uni wants to study home grown cannabis
ASX Health Stocks: Invion surges 17pc after saying its lead drug can kill anal cancer
Wellnex Life opens SPP with record Q1 FY23 sales forecast
ASX Health Stocks: Biotron expands COVID-19 study in Thailand; Noxopharm, Clarity progress pancreatic cancer research
Kazia Therapeutics lays groundwork for a possible launch in the US
ASX Health Stocks: Antisense commences trial dosing, Shine lawyers deliver historic $300m settlement
When you’re smilin’ – Wellnex to acquire premium teeth whitening brand Mr. Bright
HealthKick Podcast: PTX partners with the US’s largest cancer centre on personalised treatment
Australia’s biotech industry is thriving, with ASX-listed companies up 19% since 2019
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.